Skip to main content
. 2014 Nov 10;95(1):92–99. doi: 10.1038/labinvest.2014.134

Table 1.

List of experimental groups

1 3 7 14 days
Saline+MPSL 0 0 0 12 n=12
Imiquimod+saline 6 6 6 10 n=28
Imiquimod+MPSL 10 10 10 22 n=52
CpG-C+MPSL 0 0 0 12 n=12
Imiquimod+BAY11+MPSL 8 0 0 36 n=44